10,000 additional doses allocated to self-paid COVID-19 vaccination program
Taipei, April 27 (CNA) A total of 10,000 additional doses of COVID-19 vaccine will be set aside for residents of Taiwan to receive the vaccine as part of the self-paid program, the Central Epidemic Command Center (CECC) announced on Tuesday.
Taiwan officially began rolling out the COVID-19 vaccine on March 22, with eligibility granted to those in categories at the top of the CECC’s priority list.
On April 21, the CECC launched a separate “self-funded” program, allowing people not on the priority list to get vaccinated if they intend to travel abroad for reasons other than tourism.
Self-paid vaccinations cost up to NT $ 600 (US $ 21) per injection, while those given to people on the government’s priority list require payment of only NT $ 80 to NT $ 200.
Despite the higher cost, the program has enjoyed great popularity since its inception. A total of 7,165 people have already received their first dose under the program, while 7,909 others have made reservations to be vaccinated by May 1, CECC spokesman Chuang Jen- said on Tuesday. hsiang (莊人祥).
At the current rate, the initial 10,000 doses allocated to the program will be used up in two days, which is why the CECC has decided to increase the allocation of 10,000 additional doses for this group, the Minister of Health and Welfare said. social Chen Shih-chung (陳 時 中), who heads the CECC.
The latest CECC data shows that a total of 45,387 people in Taiwan have received their first dose of a COVID-19 vaccine.
Of the 868,000 people estimated on the priority list who were eligible, only 38,222, or 4.4%, succeeded.
Eligibility is currently open to the first six categories of people on the list. These are medical personnel, epidemic prevention officers, people at higher risk of exposure to COVID-19 due to their work, those who travel abroad for diplomatic or official business, athletes representing Taiwan in international competitions, police and military police, as well as residents. and long-term care facility staff and correctional facility workers.
To date, Taiwan has received 117,000 doses of the vaccine purchased directly from AstraZeneca, which are due to expire on June 15, as well as 199,200 doses of the same brand supplied through COVAX, which will expire on May 31.
Given the current vaccination rate, it is likely that some of the vaccine doses will expire before they can be administered.
In total, Taiwan has signed contracts to purchase 5.05 million doses of Moderna vaccine and 10 million doses of AstraZeneca, as well as 4.76 million doses of unspecified brands through the COVAX program, which has up to now assigned 1.02 million doses of AstraZeneca in Taiwan.